07Nov/13

Monoclonal Antibodies Market in Breast Cancer with 2019 Forecasts in New … – PR Web (press release)

Monoclonal Antibodies Market in Breast Cancer with 2019 Forecasts in New …
PR Web (press release)
RnRMarketResearch.com adds Latest Report on “Monoclonal Antibodies Market in Breast Cancer to 2019 – Strong Uptake of Novel HER-2 Targeted Therapies to Drive Robust Growth” to its store. Share on Twitter Share on Facebook Share on Google+ …
Breast Cancer mAbs Market Worth 10.6B by 2019 in 8 CountriesMENAFN.COM

all 2 news articles »

07Nov/13

Research and Markets: Therapy Class Overview : Rituximab Biosimilar … – Fort Mills Times

Research and Markets: Therapy Class Overview : Rituximab Biosimilar …
Fort Mills Times
Approval of Inflectra/Remsima, the first biosimilar Monoclonal antibody (Mab) from Celltrion and Hospira in EU in 2013 is a trend setter! Inflectra is a biosimilar of Johnson & Johnson’s Remicade, which is approved for RA, Crohn’s disease and several …

and more »